Breast implants class action takes aim again at Allergan’s ‘state of the art’ defence
A class action against Allergan over recalled breast implants is trying again to strike out the US drug company’s defence that there was no known causal link between its implants and a type of cancer at the time of supply.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
